日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial

口服Muvalaplin降低脂蛋白(a):一项随机临床试验

Nicholls, Stephen J; Ni, Wei; Rhodes, Grace M; Nissen, Steven E; Navar, Ann Marie; Michael, Laura F; Haupt, Axel; Krege, John H

Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve Stenosis

脂蛋白(a)对钙化性主动脉瓣狭窄患者瓣膜和心血管结局的影响

Girard, Arnaud S; Paulin, Audrey; Manikpurage, Hasanga D; Lajeunesse, Emma; Clavel, Marie-Annick; Pibarot, Philippe; Krege, John H; Mathieu, Patrick; Thériault, Sébastien; Arsenault, Benoit J

Patient-centered assessment of treatment for alpha-1 antitrypsin deficiency: literature review to identify concepts and measures for people with alpha1-antitrypsin deficiency

以患者为中心的α1-抗胰蛋白酶缺乏症治疗评估:文献综述,旨在确定α1-抗胰蛋白酶缺乏症患者的概念和评估方法

Seçinti, Ekin; Schantz, Karolina; Delbecque, Laure; Krege, John; Mangrum, Rikki; Curtis, Sarah E

Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial

拉斯米地坦长期治疗偏头痛患者:CENTURION随机试验开放标签扩展研究的治疗模式和结果的事后分析

Komori, Mika; Ozeki, Akichika; Tanji, Yuka; Kamiki, Eriko; Krege, John H; Li, Lily Qian; Suzuki, Shiho; Shibata, Mamoru; Takeshima, Takao

5-Substituted Flavones-Another Class of Potent Triplex DNA-Specific Ligands as Antigene Enhancers

5-取代黄酮——另一类强效的三链DNA特异性配体,可作为抗原增强剂

Gu, Landy; Tran, Nghia; Rangel, Vanessa M; Singh, Mandeep; Christison, Krege M; Lin-Cereghino, Geoff P; Xue, Liang

Perioperative lung function following flow controlled ventilation for robot-assisted prostatectomies in steep trendelenburg position: an observational study

采用流量控制通气进行机器人辅助前列腺切除术(患者处于陡峭头低位)的围手术期肺功能:一项观察性研究

Syrafe, Mustafa; Köhne, Wiebke; Börgers, Andre; Löwen, Heinrich; Krege, Susanne; Groeben, Harald

Influence of lymph node degeneration on metastases in prostate cancer: or why we must look for a needle in a haystack

淋巴结退行性变对前列腺癌转移的影响:或者说,为什么我们必须大海捞针

Gödde, Daniel; Degener, Stephan; Walles, Christine; Keller, Rosalie; Dreger, Nici Markus; Graf, Katharina; von Rundstedt, Friedrich-Carl; Kvasnicka, Hans Michael; Krege, Susanne; Störkel, Stephan

MEDB-81. Combined inhibition of CDK11 and EZH2 results in regression of MYC-amplified medulloblastoma

MEDB-81。CDK11 和 EZH2 的联合抑制可导致 MYC 扩增型髓母细胞瘤消退。

Hodgin, J B; Krege, J H; Reddick, R L; Korach, K S; Smithies, O; Maeda, N; Wang, Dong; Veo, Bethany; Pierce, Angela; Venkataraman, Sujatha; Vibhakar, Rajeev

The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses from Four Pooled Randomized Clinical Trials

拉米地坦治疗单次偏头痛发作后常见治疗期间出现的不良事件与疗效结果之间的关联:来自四项汇总随机临床试验的二次分析

Doty, Erin G; Hauck, Paula M; Krege, John H; Komori, Mika; Hake, Ann M; Dong, Yan; Lipton, Richard B

LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial

在接受醋酸阿比特龙联合泼尼松治疗的初治转移性去势抵抗性前列腺癌(mCRPC)患者中,保留促性腺激素释放激素(LHRH)的治疗:随机II期SPARE试验的结果

Ohlmann, Carsten-Henning; Jäschke, Michelle; Jaehnig, Peter; Krege, Susanne; Gschwend, Jürgen; Rexer, Heidrun; Junker, Kerstin; Zillmann, Roger; Rüssel, Christoph; Hellmis, Eva; Suttmann, Henrik; Janssen, Martin; Marin, Jan; Hübner, Andreas; Mathers, Michael; Gleißner, Jochen; Scheffler, Michael; Feyerabend, Susan; Telle, Jens; Klier, Jörg; Stöckle, Michael